IE45282L - Pharmaceutical tablet formulation - Google Patents
Pharmaceutical tablet formulationInfo
- Publication number
- IE45282L IE45282L IE771038A IE103877A IE45282L IE 45282 L IE45282 L IE 45282L IE 771038 A IE771038 A IE 771038A IE 103877 A IE103877 A IE 103877A IE 45282 L IE45282 L IE 45282L
- Authority
- IE
- Ireland
- Prior art keywords
- tablet formulation
- pharmaceutical tablet
- naphtho
- pyran
- tetrahydro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
There is described a pharmaceutical tablet formulation comprising an anti-allergic drug having sodium cromoglycate like activity, as active ingredient, in combination with a lubricant and a diluent (and preferably also a flow aid and a binder) the low aid, binder, lubricant and diluent containing no material capable of causing an adverse reaction in an allergic patient. Unit dosage forms of 6,7,8,9-tetrahydro-4-oxo-10-propyl-4H-naphtho¢2,3-b!pyran-2-carboxylic acid and 6,7,8,9-tetrahydro-S-hydroxy-4-oxo-10-propyl-4H-naphtho¢2,3-b!pyran-2-ccarboxylic acid are also described. The formulations and unit dosage forms are indicated for use in the treatment of allergies.
[CA1105835A]
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE2005/80A IE45283B1 (en) | 1976-05-21 | 1977-05-20 | Pharmaceutical formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB20984/76A GB1570993A (en) | 1976-05-21 | 1976-05-21 | Pharmaceutical tablet formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
IE45282L true IE45282L (en) | 1977-11-21 |
IE45282B1 IE45282B1 (en) | 1982-07-28 |
Family
ID=10155196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE1038/77A IE45282B1 (en) | 1976-05-21 | 1977-05-20 | Pharmaceutical tablet formulation |
Country Status (17)
Country | Link |
---|---|
JP (1) | JPS52143220A (en) |
AU (1) | AU511269B2 (en) |
BE (1) | BE854690A (en) |
CA (1) | CA1105835A (en) |
DE (1) | DE2722917A1 (en) |
DK (1) | DK218777A (en) |
FI (1) | FI771587A (en) |
FR (1) | FR2426460A1 (en) |
GB (1) | GB1570993A (en) |
IE (1) | IE45282B1 (en) |
IL (1) | IL52102A0 (en) |
LU (1) | LU77369A1 (en) |
NL (1) | NL7705560A (en) |
NO (1) | NO771765L (en) |
NZ (1) | NZ184141A (en) |
SE (1) | SE7705850L (en) |
ZA (1) | ZA772989B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1595220A (en) * | 1977-12-23 | 1981-08-12 | Fisons Ltd | Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane |
US5447728A (en) * | 1992-06-15 | 1995-09-05 | Emisphere Technologies, Inc. | Desferrioxamine oral delivery system |
ATE367152T1 (en) | 2001-05-01 | 2007-08-15 | Pfizer Prod Inc | PRODUCTION METHOD FOR LOW DOSE PHARMACEUTICAL COMPOSITION |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA753210B (en) * | 1974-06-14 | 1976-04-28 | Upjohn Co | Novel dosing regimen for intal biologues |
IL48360A (en) * | 1974-11-09 | 1978-12-17 | Fisons Ltd | Pharmaceutical compositions for the treatment of aphthous stomatitis comprising 1,3-bis-(2-carboxychromon-5-yloxy)-2-carboxychromon-5-yloxy)-2-hydroxypropane |
FR2292468A1 (en) * | 1974-11-30 | 1976-06-25 | Fisons Ltd | MONOCHROMES |
-
1976
- 1976-05-21 GB GB20984/76A patent/GB1570993A/en not_active Expired
-
1977
- 1977-05-16 BE BE177619A patent/BE854690A/en unknown
- 1977-05-16 IL IL52102A patent/IL52102A0/en unknown
- 1977-05-16 FR FR7714858A patent/FR2426460A1/en active Granted
- 1977-05-17 SE SE7705850A patent/SE7705850L/en unknown
- 1977-05-17 AU AU25214/77A patent/AU511269B2/en not_active Expired
- 1977-05-18 ZA ZA00772989A patent/ZA772989B/en unknown
- 1977-05-18 DK DK218777A patent/DK218777A/en not_active Application Discontinuation
- 1977-05-18 LU LU77369A patent/LU77369A1/xx unknown
- 1977-05-18 NZ NZ184141A patent/NZ184141A/en unknown
- 1977-05-19 FI FI771587A patent/FI771587A/fi not_active Application Discontinuation
- 1977-05-19 CA CA278,833A patent/CA1105835A/en not_active Expired
- 1977-05-19 JP JP5712777A patent/JPS52143220A/en active Pending
- 1977-05-20 IE IE1038/77A patent/IE45282B1/en unknown
- 1977-05-20 NL NL7705560A patent/NL7705560A/en not_active Application Discontinuation
- 1977-05-20 NO NO771765A patent/NO771765L/en unknown
- 1977-05-20 DE DE19772722917 patent/DE2722917A1/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
DE2722917A1 (en) | 1977-12-01 |
NO771765L (en) | 1977-11-22 |
SE7705850L (en) | 1977-11-22 |
AU511269B2 (en) | 1980-08-07 |
NL7705560A (en) | 1977-11-23 |
LU77369A1 (en) | 1977-12-13 |
IE45282B1 (en) | 1982-07-28 |
DK218777A (en) | 1977-11-22 |
FR2426460A1 (en) | 1979-12-21 |
BE854690A (en) | 1977-11-16 |
FR2426460B1 (en) | 1983-04-29 |
NZ184141A (en) | 1979-06-19 |
JPS52143220A (en) | 1977-11-29 |
AU2521477A (en) | 1978-11-23 |
CA1105835A (en) | 1981-07-28 |
GB1570993A (en) | 1980-07-09 |
FI771587A (en) | 1977-11-22 |
IL52102A0 (en) | 1977-07-31 |
ZA772989B (en) | 1978-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE790756L (en) | Cerebral therapeutic agent | |
ES8105292A1 (en) | Urea derivatives for use in the treatment of fat metabolism disorders. | |
DE3686483D1 (en) | DRUG. | |
DE69327432D1 (en) | MEDICINE FOR Wounds and Hemorrhoid | |
AU1923088A (en) | Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents | |
PT86186A (en) | Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same | |
RU93032613A (en) | PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PATIENTS WITH PROLONGED COAGULATION TIME, METHOD OF TREATING PATIENTS, USING THE EPI INHIBITOR FOR OBTAINING THE PHARMACEUTICAL PREPARATION | |
ES2088959T3 (en) | 11-BETA-ARIL-4-PREMIERE, PROCEDURE FOR ITS PREPARATION AND APPLICATION AS A MEDICINAL PRODUCT. | |
AU625402B2 (en) | Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances | |
BE890808A (en) | NOVEL GALENIC FORM OF ADMINISTRATION OF METOCLOPRAMIDE, ITS PREPARATION METHOD AND MEDICINAL PRODUCT COMPRISING THIS NOVEL FORM | |
KR970032872A (en) | Drugs for the treatment of skin damage containing acetylsalicylic acid | |
AU1950388A (en) | Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same | |
JPS5218813A (en) | Plasters for the relief of cutaneous diseases | |
US4117120A (en) | Medication for herpes simplex and canker sores | |
NL7705855A (en) | PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE SUBSTITUATED BENZAMIDES AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS. | |
IE45282L (en) | Pharmaceutical tablet formulation | |
IL52792A (en) | 5-substituted-4-amino-thiophene-3-carboxylic acid derivatives,their preparation and antiobesity and blood lipid lowering pharmaceutical compositions containing them | |
GB2021409A (en) | Pharmaceutical composition | |
DE3874390D1 (en) | CARBOXYSTYRENE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT AS AN ACTIVE SUBSTANCE. | |
EP0310126A3 (en) | Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines | |
IE831551L (en) | Eye ointment. | |
CY1228A (en) | Bronchospasmolytically active compounds,processes for their preparation,pharmaceutical preparations containing them and their medicinal use | |
MY114218A (en) | The use of bambuterol or a pharmaceutically acceptable salt thereof, to make lipid lowering pharmaceutical preparations. | |
JPS6485914A (en) | Use of n-(2-(diethylamino)ethyl)-2-methoxy-4- ((1-h-4,5-dihydro-2-imidazolyl)amino)-5- chlorobenzamide as antianxiety and antipsychotic | |
JPS6442437A (en) | Antiviral external drug and manufacture |